在瘤中心生命末期的全身抗癌疗法中的侵略性
José António Ferraz-Gonçalves1, Inês Silva2, Patrícia Redondo2
1Instituto Português de Oncologia, Porto-Palliative Care Service, Porto, Portugal.
Porto biomedical journal
|March 11, 2024
概括
使用全身抗癌疗法 (SACT) 的侵袭性生命终结癌症治疗是常见的. 这项研究发现,在生命的最后一个月和一周中,SACT的使用增加了,特别是在转移性疾病中.
科学领域:
- 在瘤学瘤学.
- 抚慰性护理是一种缓解性护理.
- 癌症治疗方法 癌症治疗方法
背景情况:
- 生命末期 (EoL) 的侵袭性癌症治疗在全球范围内有所不同.
- 了解EoL治疗模式对于改善患者护理至关重要.
研究的目的:
- 评估癌症治疗在EoL的攻击性在瘤中心.
- 确定与临近死亡时接受全身抗癌疗法 (SACT) 相关的因素.
主要方法:
- 对2017年去世的成年患有固体瘤患者的回顾性研究.
- 专注于全身抗癌疗法 (SACT),不包括激素治疗.
- 在生命的最后一个月和一周内分析了SACT的使用情况.
主要成果:
- 在2024名死亡患者中,有37%患有转移性疾病.
- 在27%的人群中,SACT是在生命的最后一个月和5%在生命的最后一个星期中被给予的.
- 转移性疾病与临近死亡时接受SACT显著相关.
结论:
- 在EoL的癌症治疗攻击性相对普遍.
- 有证据表明,在生命的最后一个月和一周中,SACT使用量增加.
- 需要进一步的研究来优化EOL护理和治疗策略.
相关概念视频
Nursing Ethical Principles II
965
Ethical principles are essential in guiding nurses to fulfill their responsibilities, focusing on the quality of nursing care and decision-making. These principles, including autonomy, beneficence, non-maleficence, justice, and fidelity, shape the ethical framework within healthcare settings.
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
965
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Ethical Issues
953
Nurses are essential in patient care, upholding the ethical principles of their profession and effectively navigating ethical dilemmas. Neglecting ethical issues can lead to inadequate patient care, compromised therapeutic relationships, and moral distress among healthcare workers.
Ethical Concerns in Healthcare:
Ethical Concerns in Healthcare:
953
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Cancer Survival Analysis
345
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
345


